Research Paper Volume 16, Issue 10 pp 8944—8964
SLAMF8 can predict prognosis of pan-cancer and the immunotherapy response effectivity of gastric cancer
Figure 17. Correlation analysis between SLAMF8 expression and immunotherapy. (A) Representative immunohistochemical staining of SLAMF8 in STAD tissue, Magnification ×100. (B) Representative immunohistochemical staining of SLAMF8 in STAD tissue, Magnification ×400. (C) Different expression of SLAMF8 in STAD tissue and matched adjacent noncancerous tissues. ***P < 0.001. (D) Different therapeutic effectiveness of albumin paclitaxel combined with Sindillizumab between high expression of SLAMF8 and low expression of SLAMF8 in 48 patients who were recurrent after radical gastric cancer surgery. (E–G) Correlation analysis between SLAMF8 expression and the therapeutic effectiveness of immunotherapy based on Melanoma-PRJEB23709_ALL, 3709_ANTI-PD-1 and Melanoma-PRJEB23709_anti-CTLA-4+anti-PD-1 datasets downloaded from TIGER database.